Ann Taylor currently serves on the Board of Directors of Comanche Biopharma, a private biopharmaceutical company, Unlearn.AI, Terns Pharmaceuticals, and Yleana Leadership Foundation.
Ann was most recently Chief Medical Officer of AstraZeneca (AZ) until her retirement in August 2021, where she oversaw the full range of clinical development activities. Previously, she was the Vice President, Global Clinical Development at MedImmune, which became a wholly owned subsidiary of AstraZeneca. Earlier in her career, Ann held various R&D and leadership roles at Novartis Institute for BioMedical Research for over ten years and at Pfizer for seven years.
She is a Board-certified endocrinologist and received her M.D. from Harvard Medical School. She received her B.A. in Biology magna cum laude from the University of California, San Diego.

Dr. Ann Taylor
Retired, Former Chief Medical Officer, AstraZeneca